Detalhe da pesquisa
1.
A Phase I Study of a Combination of Liposomal Irinotecan and Veliparib in Solid Tumors.
Oncologist
; 28(5): 460-e298, 2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37010988
2.
Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes.
Cancer Discov
; 13(4): 928-949, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36715552
3.
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical Trial.
JAMA Oncol
; 9(12): 1669-1677, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37824137
4.
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial.
Clin Cancer Res
; 29(18): 3603-3611, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37227187
5.
Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models.
Nat Commun
; 13(1): 2023, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35440132
6.
Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies.
Sci Transl Med
; 13(578)2021 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33504652
7.
Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study.
J Thorac Oncol
; 14(8): 1447-1457, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31063862
8.
Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis).
J Clin Oncol
; 35(14): 1561-1569, 2017 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28350521